Nuvation Bio IncNYSE:NUVB
- LAST PRICE3.0400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.0100/ 3
- Ask / Lots3.1800/ 50
- Open / Previous Close3.0900 / 3.0400
- Day Range
- 52 Week Range
- Volume1,500,791
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NUVB |
|---|---|---|
| 09:32 ET | 23931 | 3.07 |
| 09:34 ET | 2995 | 3.05 |
| 09:36 ET | 1371 | 3.05 |
| 09:38 ET | 1100 | 3.07 |
| 09:39 ET | 5042 | 3.065 |
| 09:41 ET | 8173 | 3.0797 |
| 09:43 ET | 6139 | 3.085 |
| 09:45 ET | 10021 | 3.12 |
| 09:48 ET | 388 | 3.12 |
| 09:50 ET | 18165 | 3.135 |
| 09:52 ET | 8660 | 3.1205 |
| 09:54 ET | 17130 | 3.13 |
| 09:56 ET | 12746 | 3.135 |
| 09:57 ET | 2100 | 3.1352 |
| 09:59 ET | 15692 | 3.165 |
| 10:01 ET | 2758 | 3.17 |
| 10:03 ET | 1140 | 3.16 |
| 10:06 ET | 2270 | 3.145 |
| 10:08 ET | 7389 | 3.145 |
| 10:10 ET | 4424 | 3.1307 |
| 10:12 ET | 10241 | 3.135 |
| 10:14 ET | 1318 | 3.14 |
| 10:15 ET | 6631 | 3.125 |
| 10:17 ET | 3695 | 3.105 |
| 10:19 ET | 25020 | 3.1 |
| 10:21 ET | 4516 | 3.095 |
| 10:24 ET | 2336 | 3.085 |
| 10:26 ET | 6920 | 3.085 |
| 10:28 ET | 564 | 3.085 |
| 10:30 ET | 6400 | 3.09 |
| 10:32 ET | 6941 | 3.095 |
| 10:33 ET | 2490 | 3.11 |
| 10:35 ET | 10402 | 3.105 |
| 10:37 ET | 8235 | 3.12 |
| 10:39 ET | 22855 | 3.115 |
| 10:42 ET | 2627 | 3.11 |
| 10:44 ET | 1206 | 3.115 |
| 10:46 ET | 44333 | 3.09 |
| 10:48 ET | 8157 | 3.105 |
| 10:50 ET | 300 | 3.11 |
| 10:51 ET | 2300 | 3.105 |
| 10:53 ET | 9776 | 3.085 |
| 10:55 ET | 7302 | 3.08 |
| 10:57 ET | 1566 | 3.08 |
| 11:00 ET | 7123 | 3.07 |
| 11:02 ET | 986 | 3.07 |
| 11:04 ET | 20454 | 3.095 |
| 11:06 ET | 2502 | 3.095 |
| 11:08 ET | 1348 | 3.095 |
| 11:09 ET | 11101 | 3.08 |
| 11:11 ET | 6194 | 3.07 |
| 11:13 ET | 300 | 3.075 |
| 11:15 ET | 4777 | 3.085 |
| 11:18 ET | 1456 | 3.085 |
| 11:20 ET | 1700 | 3.085 |
| 11:22 ET | 700 | 3.085 |
| 11:24 ET | 2100 | 3.085 |
| 11:26 ET | 12657 | 3.075 |
| 11:27 ET | 3090 | 3.075 |
| 11:29 ET | 9676 | 3.065 |
| 11:31 ET | 617 | 3.065 |
| 11:33 ET | 2275 | 3.065 |
| 11:36 ET | 16300 | 3.065 |
| 11:38 ET | 10060 | 3.07 |
| 11:40 ET | 2250 | 3.065 |
| 11:42 ET | 1586 | 3.07 |
| 11:44 ET | 7631 | 3.05 |
| 11:45 ET | 4797 | 3.045 |
| 11:47 ET | 300 | 3.045 |
| 11:49 ET | 900 | 3.045 |
| 11:51 ET | 400 | 3.045 |
| 11:54 ET | 9386 | 3.04 |
| 11:56 ET | 100 | 3.045 |
| 11:58 ET | 541 | 3.04 |
| 12:00 ET | 8680 | 3.055 |
| 12:02 ET | 200 | 3.055 |
| 12:03 ET | 500 | 3.06 |
| 12:05 ET | 1100 | 3.055 |
| 12:07 ET | 12976 | 3.055 |
| 12:09 ET | 200 | 3.055 |
| 12:12 ET | 2147 | 3.055 |
| 12:14 ET | 300 | 3.06 |
| 12:16 ET | 927 | 3.055 |
| 12:18 ET | 6823 | 3.041 |
| 12:20 ET | 6557 | 3.045 |
| 12:21 ET | 700 | 3.045 |
| 12:23 ET | 300 | 3.045 |
| 12:25 ET | 1600 | 3.045 |
| 12:27 ET | 6129 | 3.055 |
| 12:30 ET | 300 | 3.05 |
| 12:32 ET | 385 | 3.05 |
| 12:34 ET | 400 | 3.05 |
| 12:36 ET | 500 | 3.055 |
| 12:38 ET | 500 | 3.05 |
| 12:39 ET | 700 | 3.05 |
| 12:41 ET | 974 | 3.055 |
| 12:43 ET | 9195 | 3.045 |
| 12:45 ET | 2400 | 3.04 |
| 12:48 ET | 10358 | 3.06 |
| 12:50 ET | 900 | 3.055 |
| 12:52 ET | 998 | 3.055 |
| 12:54 ET | 987 | 3.055 |
| 12:56 ET | 17347 | 3.05 |
| 12:57 ET | 5823 | 3.04 |
| 12:59 ET | 200 | 3.045 |
| 01:01 ET | 933 | 3.05 |
| 01:03 ET | 2150 | 3.05 |
| 01:06 ET | 600 | 3.045 |
| 01:08 ET | 800 | 3.045 |
| 01:10 ET | 300 | 3.045 |
| 01:12 ET | 6056 | 3.035 |
| 01:14 ET | 1123 | 3.035 |
| 01:15 ET | 1400 | 3.035 |
| 01:17 ET | 2100 | 3.04 |
| 01:19 ET | 2723 | 3.035 |
| 01:21 ET | 738 | 3.03 |
| 01:24 ET | 1200 | 3.03 |
| 01:26 ET | 800 | 3.035 |
| 01:28 ET | 1100 | 3.035 |
| 01:30 ET | 1000 | 3.04 |
| 01:32 ET | 2900 | 3.035 |
| 01:33 ET | 1050 | 3.035 |
| 01:35 ET | 1850 | 3.035 |
| 01:37 ET | 1150 | 3.035 |
| 01:39 ET | 45194 | 3.035 |
| 01:42 ET | 1510 | 3.035 |
| 01:44 ET | 756 | 3.035 |
| 01:46 ET | 600 | 3.035 |
| 01:48 ET | 4100 | 3.035 |
| 01:50 ET | 8834 | 3.045 |
| 01:51 ET | 11367 | 3.035 |
| 01:53 ET | 16311 | 3.045 |
| 01:55 ET | 26361 | 3.045 |
| 01:57 ET | 13559 | 3.045 |
| 02:00 ET | 10600 | 3.05 |
| 02:02 ET | 3521 | 3.045 |
| 02:04 ET | 17947 | 3.035 |
| 02:06 ET | 300 | 3.035 |
| 02:08 ET | 400 | 3.035 |
| 02:09 ET | 300 | 3.035 |
| 02:11 ET | 600 | 3.03 |
| 02:13 ET | 900 | 3.035 |
| 02:15 ET | 1000 | 3.03 |
| 02:18 ET | 1268 | 3.035 |
| 02:20 ET | 12501 | 3.035 |
| 02:22 ET | 9130 | 3.045 |
| 02:24 ET | 599 | 3.05 |
| 02:26 ET | 600 | 3.045 |
| 02:27 ET | 2300 | 3.045 |
| 02:29 ET | 10400 | 3.045 |
| 02:31 ET | 2950 | 3.045 |
| 02:33 ET | 14045 | 3.06 |
| 02:36 ET | 1100 | 3.055 |
| 02:38 ET | 2043 | 3.05 |
| 02:40 ET | 23942 | 3.055 |
| 02:42 ET | 1886 | 3.055 |
| 02:44 ET | 700 | 3.05 |
| 02:45 ET | 400 | 3.055 |
| 02:47 ET | 500 | 3.055 |
| 02:49 ET | 14627 | 3.065 |
| 02:51 ET | 8132 | 3.065 |
| 02:54 ET | 700 | 3.065 |
| 02:56 ET | 1953 | 3.065 |
| 02:58 ET | 1587 | 3.06 |
| 03:00 ET | 962 | 3.06 |
| 03:02 ET | 20459 | 3.065 |
| 03:03 ET | 760 | 3.065 |
| 03:05 ET | 400 | 3.06 |
| 03:07 ET | 11941 | 3.055 |
| 03:09 ET | 1900 | 3.055 |
| 03:12 ET | 2281 | 3.055 |
| 03:14 ET | 3821 | 3.055 |
| 03:16 ET | 2421 | 3.05 |
| 03:18 ET | 1100 | 3.05 |
| 03:20 ET | 1914 | 3.05 |
| 03:21 ET | 1878 | 3.05 |
| 03:23 ET | 1988 | 3.05 |
| 03:25 ET | 3500 | 3.055 |
| 03:27 ET | 6771 | 3.05 |
| 03:30 ET | 1340 | 3.045 |
| 03:32 ET | 1400 | 3.04 |
| 03:34 ET | 1600 | 3.04 |
| 03:36 ET | 1900 | 3.045 |
| 03:38 ET | 7936 | 3.04 |
| 03:39 ET | 1863 | 3.04 |
| 03:41 ET | 2631 | 3.04 |
| 03:43 ET | 2192 | 3.04 |
| 03:45 ET | 3182 | 3.04 |
| 03:48 ET | 4449 | 3.045 |
| 03:50 ET | 4826 | 3.04 |
| 03:52 ET | 15234 | 3.04 |
| 03:54 ET | 6621 | 3.04 |
| 03:56 ET | 15872 | 3.04 |
| 03:57 ET | 27061 | 3.04 |
| 03:59 ET | 106302 | 3.04 |
Jun 3, 2024
DJ Nuvation Bio Price Target Maintained With a $8.00/Share by HC Wainwright & Co., from 6:46AM ET on Monday Jun 03, 2024 by Dow Jones
6:46AM ET on Monday Jun 03, 2024 by Dow Jones
Jun 1, 2024
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting, from 8:10AM ET on Saturday Jun 01, 2024 by Dow Jones
8:10AM ET on Saturday Jun 01, 2024 by Dow Jones
May 29, 2024
Nuvation Bio to Present at the Jefferies Global Healthcare Conference, from 4:05PM ET on Wednesday May 29, 2024 by Dow Jones
4:05PM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nuvation Bio Inc | 739.0M | -9.7x | --- |
89Bio Inc | 719.2M | -3.8x | --- |
ARS Pharmaceuticals Inc | 782.9M | -15.5x | --- |
Viridian Therapeutics Inc | 785.7M | -2.8x | --- |
Mesoblast Ltd | 736.0M | -4.7x | --- |
CARGO Therapeutics Inc | 683.1M | -5.4x | --- |
Company Information
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Contact Information
- Headquarters
- 357 Tehama Street, Floor 3SAN FRANCISCO, CA, United States 94103
- Phone
- 415-754-3517
- Fax
- 302-636-5454
Executives
- Independent Chair of the Board
- Daniel Welch
- President, Chief Executive Officer, Founder, Director
- David Hung
- Principal Financial and Accounting Officer, Vice President - Finance
- Moses Makunje
- Chief Executive Officer of AnHeart Therapeutics and Director
- Junyuan Wang
- Chief People Officer
- Stacy Markel
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $739.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 247.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.40 |
EPS | $-0.31 |
Book Value | $2.76 |
P/E Ratio | -9.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
